Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PCSK9 inhibitors
PCSK9 inhibitors
AstraZeneca throws its hat into the oral PCSK9 ring
Pharmaphorum
Wed, 05/29/24 - 11:28 am
AstraZeneca
PCSK9 inhibitors
cholesterol
AZD0780
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Fierce Biotech
Fri, 08/25/23 - 09:57 am
Merck
PCSK9 inhibitors
clinical trials
cardiovascular disease
cholesterol
MK-0616
Cholesterol-focused Esperion loses appetite for oral PCSK9 collab with Serometrix
Fierce Biotech
Tue, 08/1/23 - 11:57 am
Esperion Therapeutics
R&D
Serometrixjm
PCSK9 inhibitors
cholesterol
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Fierce Biotech
Tue, 02/28/23 - 10:03 am
Junshi Biosciences
Amgen
Sanofi
China
clinical trials
PCSK9 inhibitors
PCSK9 pipeline shows signs of saturation
EP Vantage
Tue, 09/27/22 - 10:21 am
AstraZeneca
ION449
Ionis Pharmaceuticals
Novartis
Leqvio
PCSK9 inhibitors
Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?
Forbes
Tue, 02/1/22 - 10:48 am
Merck
cholesterol
PCSK9 inhibitors
MK-0616
Zocor
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
BioSpace
Mon, 11/15/21 - 11:55 pm
Merck
PCSK9 inhibitors
Amgen
Repatha
Esperion
Sanofi
Regeneron
Praluent
Merck looks to ditch the needles with its next-gen oral PCSK9 inhibitor for high cholesterol
Endpoints
Mon, 11/15/21 - 10:57 am
Merck
MK-0616
oral PCSK9 inhibitors
PCSK9 inhibitors
Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron
Fierce Pharma
Tue, 06/22/21 - 11:56 am
Amgen
PCSK9 inhibitors
Sanofi
Regeneron
patents
Repatha
AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics
Pharmaforum
Thu, 09/17/20 - 10:38 am
AstraZeneca
Dogma Therapeutics
cholesterol
PCSK9 inhibitors
ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half
Fierce Biotech
Sat, 03/28/20 - 11:43 pm
Novartis
ACC
PCSK9 inhibitors
inclisiran
MedCo's PCSK9 challenger steals the show at ESC with winning data
Fierce Pharma
Mon, 09/2/19 - 12:27 pm
Medicines Company
ESC
PCSK9 inhibitors
inclisiran
Repatha
Praluent
European Society of Cardiology
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Wed, 08/28/19 - 10:52 pm
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Tue, 08/27/19 - 12:04 pm
Amgen
Regeneron
Sanofi
Praluent
Repatha
Medicines Company
PCSK9 inhibitors
inclisiran
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
Xconomy
Mon, 08/26/19 - 09:49 am
PCSK9 inhibitors
Medicines Company
inclisiran
insurers
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
Mon, 06/10/19 - 10:31 am
The Medicines Company
Amgen
Sanofi
Regeneron
inclisiran
PCSK9 inhibitors
Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen
Biopharma Dive
Mon, 02/11/19 - 12:23 pm
Regeneron
Sanofi
Amgen
Praluent
Repatha
drug pricing
PCSK9 inhibitors
New drug options, risk factors added to US heart guidelines
Reuters
Sun, 11/11/18 - 09:16 pm
statins
PCSK9 inhibitors
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Fierce Pharma
Thu, 08/9/18 - 03:57 pm
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Supreme Court
Praluent
Repatha
Are These Disappointing Drugs Back on Track to Billions?
Motley Fool
Sun, 05/6/18 - 01:33 pm
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
Praluent
Repatha
Pages
1
2
3
4
5
6
7
8
next ›
last »